[On the inflammation inhibitory effect of (-)-alpha-bisabolol, an essential component of chamomilla oil].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002351:Carrageenan; D003516:Cycloparaffins / Q000627:therapeutic use / Q000633:toxicity; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D006099:Granuloma / Q000188:drug therapy*; D007213:Indomethacin / Q000627:therapeutic use / Q000633:toxicity; D008297:Male; D051379:Mice; D009822:Oils, Volatile / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use / Q000633:toxicity; D051381:Rats; D013729:Terpenes / Q000627:therapeutic use* / Q000633:toxicity
D000893:Anti-Inflammatory Agents; D003516:Cycloparaffins; D009822:Oils, Volatile; D013729:Terpenes; D002351:Carrageenan; D010653:Phenylbutazone; D007213:Indomethacin
Zur entzündungshemmenden Wirkung von (-)-alpha-Bisabolol, einem wesentlichen Bestandteil des Kamillenöls.